The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2025

Filed:

May. 01, 2020
Applicant:

Karyopharm Therapeutics Inc., Newton, MA (US);

Inventors:

Brian C. Austad, Tewksbury, MA (US);

David G. Roe, Rockwood, CA;

Assignee:

Karyopharm Therapeutics Inc., Newton, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 249/08 (2006.01); C07D 403/12 (2006.01);
U.S. Cl.
CPC ...
C07D 249/08 (2013.01); C07D 403/12 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention provides an improved process for preparation of the (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid (referred to as compound of the structural formula (III)), which is a useful key intermediate for the synthesis of Selinexor ((Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide). The process comprises reaction of the compound of the structural formula (I) (as described herein) with the compound of the structural formula (II) (as described herein) in the presence of a catalyst, an organic base and an ether-containing solvent. The subsequent hydrolysis of the formed compound of the structural formula (IIIa) (as described herein) is performed without isolation of the compound of the structural formula (IIIa), providing compound of the structural formula (III) in high yield and stereoselectivity.


Find Patent Forward Citations

Loading…